http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-775-G2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8654b3f7649d7b5ff5036530a378d2a8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-38 |
| filingDate | 1997-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f4e4075f6371bb21a43bcd34fc9d80f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81a26ea6fb1febbee5f681e6041f1a5 |
| publicationDate | 1998-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MD-775-G2 |
| titleOfInvention | Process for obtaining 2-hydroxynaphthyl-1-methylene hydrazone 5-nitro-2-furaldehyde |
| abstract | The invention relates to the process for obtaining the biologically active organic compound of the hydrazone class, namely 2-hydroxynaphthyl-1-methynhydrazone 5-nitro-2-furaldehyde. This substance can be applied in medicine, as it is characterized by reduced toxicity (LD50> 1000 mg / kg), and in terms of bacteriostatic activity against bacteria of the genus Staphylococcus exceeds 1.3 ... 93 times the best preparations. The essence of the invention is that in the process, which involves the consecutive condensation of hydrazine, initially with 2-hydroxy-1-naphtaldehyde, and then with 5-nitro-2-furaldehyde, the succession of hydrazine condensation changes. The technical result of the invention consists in the synthesis of 2-hydroxynaphthyl-1-methynhydrazone 5-nitro-2-furaldehyde with a high yield (1.3 times). |
| priorityDate | 1997-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.